Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zai Lab (ZLAB) Share-based Compensation (2020 - 2025)

Zai Lab's Share-based Compensation history spans 6 years, with the latest figure at $16.9 million for Q3 2025.

  • For Q3 2025, Share-based Compensation rose 0.76% year-over-year to $16.9 million; the TTM value through Sep 2025 reached $66.9 million, down 9.41%, while the annual FY2024 figure was $70.7 million, 11.28% down from the prior year.
  • Share-based Compensation for Q3 2025 was $16.9 million at Zai Lab, roughly flat from $17.0 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $22.0 million in Q3 2023 and bottomed at $7.3 million in Q1 2021.
  • The 5-year median for Share-based Compensation is $16.8 million (2024), against an average of $15.9 million.
  • The largest annual shift saw Share-based Compensation skyrocketed 184.93% in 2021 before it fell 23.63% in 2024.
  • A 5-year view of Share-based Compensation shows it stood at $12.6 million in 2021, then increased by 23.41% to $15.6 million in 2022, then skyrocketed by 31.56% to $20.5 million in 2023, then decreased by 15.79% to $17.2 million in 2024, then dropped by 1.83% to $16.9 million in 2025.
  • Per Business Quant, the three most recent readings for ZLAB's Share-based Compensation are $16.9 million (Q3 2025), $17.0 million (Q2 2025), and $15.8 million (Q1 2025).